Lilly's Competitive Clinical Research Grant
Lilly's Competitive Clinical Research Grant funds independent clinical research in Lilly’s priority areas, with grantees leading study design and conduct.
Funder: Eli Lilly and Company
Due Dates: Rolling (open submission via RFPs)
Funding Amounts: Award size and duration vary by project; funding and/or study drug support provided based on proposal scope and alignment with Lilly's interests.
Summary: Supports independent, investigator-initiated clinical research aligned with Lilly’s specified areas of interest through a global RFP process.
Key Information: Grantee retains full responsibility for study design, conduct, and regulatory sponsorship.
Description
Lilly's Competitive Clinical Research Grant is designed to support external, investigator-initiated research that aligns with Eli Lilly and Company’s scientific and therapeutic priorities. The program operates through publicly posted Requests for Proposal (RFPs) that specify research interests and review timelines. Proposals are evaluated by global committees of Lilly medical and scientific staff, and external experts may be involved in the final selection. Approved projects receive funding and/or study drug support, but the grantee retains full responsibility for the design, conduct, and regulatory sponsorship of the research.
